The Benefits of Dietary and Micro-nutritional Management for Well-being at Work
NCT ID: NCT06137898
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
200 participants
OBSERVATIONAL
2024-01-31
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Status and Emotional Well-being of the Worker-consumer in the Food Supply Chain.
NCT06896877
Effect of Ultra Processed Versus Unprocessed Diets on Energy Intake
NCT03407053
Worksite Nutrition Study
NCT00481897
Human Intervention Study for Validating Foods With Improved Nutrient Profile
NCT04113837
Effects of a 4-week Raw, Plant-based Diet on Anthropometric and Cardiovascular Risk Factors
NCT03134235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
If eligible, the participant will download a data collection application onto his or her smartphone, and will be provided with an identifier and access code.
As part of the program, dietary hygiene and micro-nutritional recommendations will be proposed on the basis of the results of a biological (blood test) and nutritional (interview with the doctor) assessment. If necessary, the doctor may prescribe additional blood tests on a regular basis, and will carry out nutritional assessments to adapt the program's management.
The program will be organized into 5 visits:
* a first visit V0 (micro-nutritional interview) with a biological check-up ;
* a second V1 visit (within a fortnight of the initial visit) to review all the results of the initial assessment and, if necessary, to implement hygienic-dietary and/or nutritional recommendations (in the form of cards) and/or a micro-nutritional prescription;
* quarterly follow-up visits (at 3 and 6 months) and a visit at 1 year to carry out check-ups.
These visits can take place face-to-face with an investigating physician, or by teleconsultation.
A statistical analysis plan will precisely indicate the populations studied, the analysis procedures, the treatment of missing data envisaged, the statistical tests for each variable and for the analysis of the primary and secondary judgment criteria to be used.
The threshold of statistical significance will be defined at the risk alpha = 0.05.
Trial data will be collected :
* by investigators for biological and clinical data on the e-CRF
* by participants on their smartphones using the data acquisition system for self-questionnaires.
Description of the population:
Descriptions of subjects included in the study will be made by mean and standard deviation for quantitative variables and by frequency and numbers for qualitative variables.
Analysis of endpoints:
Changes in WHO5, MSP9 scores and biological variables will be analyzed using a repeated-measures ANOVA. The same analyses will be carried out on secondary criteria. Correlations between changes in WHO5 and MSP-9 scores and changes in biological and clinical and clinical data.
Sample size:
The required sample size is based on the evolution of the WHO-5 global score between the initial visit and the 6-month follow-up visit using a two-tailed paired t-test with an estimated mean evolution of 5, an estimated standard deviation of 19 (12) and a confidence level of 90. 154 subjects are required, which is rounded up to 200 to account for unexploitable records (≈10%) or premature study withdrawals (≈10%).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biological check-up
Blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having freely declared to the investigator that he/she does not object to his/her participation in the study the study and to the collection of data strictly necessary for the study, after having received informed oral and written information from the investigator
* Have a smartphone compatible with the secure data collection application
Exclusion Criteria
* Participating in another study or in the exclusion period
* Person under court protection
18 Years
62 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Larena SAS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carole PERRIN
Role: PRINCIPAL_INVESTIGATOR
CEN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CEN
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Carole PERRIN
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PIL-RIPH3-MEDEIS-023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.